Adherence, MedicationYouthPrEPNCT03778892
Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thailand
A study testing 'Project Raincoat' Mobile Phone Application in people with Adherence, Medication and Adolescent Behavior, run by Chulalongkorn University at 1 site in Thailand.
Trial summary
A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence. Read more about this study
- Who is it for?
- Ages 15 to 19 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Adherence, Medication, Adolescent Behavior, HIV Prevention
- What is being tested?
- 'Project Raincoat' Mobile Phone Application
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteThailand
- Study dates
- 1 Mar 2018to 15 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 19 years
- Men only
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Adolescent men who have sex with men
- At high risk of HIV infection (have at least one of the following)
- More than 1 sexual partner in the last 6 months
- Irregular condom use during sexual intercourse
- HIV positive sexual partner
- Age 15 to under 20 years old
Show all 9Show fewer
- A desire to take PrEP to prevent HIV infection
- Tested HIV negative within 1 month of enrolment
- Able to provide written consent or assent to take part in the clinical trial
Who cannot join
- Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy
Trial locations and contacts
1 site in 1 country.
About this study
A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.
Read the detailed description
OBJECTIVES
Primary Objectives:
To study PrEP adherence in adolescent MSM who are at high risk of HIV acquisition.
Secondary Objectives:
To study
- Rates of HIV infection
- Rates of sexually transmitted infections (STIs)
- Sexual risk taking behaviours In adolescent MSM who are at high risk of HIV infection.
HYPOTHESES:
- The investigators hypothesize that youth-focused interventions will produce superior adherence to PrEP from 50% with standard interventions to 70% with youth focused interventions.
- The investigators hypothesize that adherence to PrEP varies by the level of risk behavior one perceives. Participants who take higher risk behaviors will be more likely to adhere to PrEP than participants who have lower risk behaviors. STIs are expected to be more common among participants with higher levels of adherence if they are participants who have higher risk behaviors.
RESEARCH DESIGN:
Randomised control trial, behavioural intervention
RESEARCH METHODOLOGY
- Study population Volunteers aged 15 to under 20 years at high risk of HIV infection receiving PrEP under the 'Princess PrEP' project
- Inclusion Criteria
- Adolescent men who have sex with men
- At high risk of HIV infection (have at least one of the following)
- More than 1 sexual partner in the last 6 months
- Irregular condom use during sexual intercourse
- HIV positive sexual partner
- Age 15 to under 20 years old
- A desire to take PrEP to prevent HIV infection
- Tested HIV negative within 1 month of enrolment
- Able to provide written consent or assent to take part in the clinical trial
- Exclusion criteria Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy
- Study recruitment
- Eligible persons presenting to the Thai Red Cross Anonymous Clinic (TRCARC) or its affiliated community based organizations (Rainbow Sky Association Thailand (RSAT) Ramkamhaeng, Sex Workers in Action Group (SWING) Bangkok will be asked by counsellors on their interest to join the study.
- Number of participants to be studied: 200
- Informed consent process/ informed assent The research doctor will explain to potential participants about the purposes of the study and allow them to ask any questions they may have on it, and will be given time to make their decision. If a participant chooses to join the study, they will be asked for their written consent/assent and a copy of the informed consent/assent form given to them.
- Participants aged between 15 and 18 will be asked for assent. As this is a study on sexual health where disease prevention is of utmost concern, parental consent will not be asked for.
- Participants aged 18 to 19 will be asked for consent.
- Study procedure After informed consent or assent, all youth will commence once daily TFV/FTC 200/300mg. Volunteers will be randomized into arms 1 (standard intervention) or 2 (novel intervention strategy). Both groups will receive youth-focused counselling by trained counsellors and have access to an adolescent-friendly sexual health promotion website and social media page where they can get in contact with counsellors, doctors, fellow adolescents and function as a platform through which they can learn about good sexual health practices. Adolescents in arm 2 (novel intervention strategy) will also receive access to a mobile phone application.
Youth-focused counselling Counsellors will provide counselling that is friendly, non-judgmental and utilize motivational interviewing techniques where sessions are more collaborative rather than didactic.
Mobile Phone Application
- Password protection will ensure user privacy
- Will allow users to input weekly data on their:
- Sexual risk e.g. no sexual activity, sex with condoms, sex without condoms
- PrEP use e.g. whether or not participants take their PrEP
- The application will calculate a percentage of protection users have based on their data entry
- Points can be accumulated for application use, data input to the application, for attending appointments and also for normal STI and HIV screening results. Points can be redeemed for cash
- The overall goal of the application is to increase participant awareness of self-risk and motivation to protect themselves against HIV and STI infection
Participants will be followed up at months 1, 3 and 6. At each visit, participants will complete a questionnaire on drug adherence and sexual health risk behaviours.
STI testing will be done as an indirect marker of condom use at visits 1 and 6. This will involve blood testing for syphilis serology and nucleic acid amplification testing for gonorrhea, and chlamydia on swab samples.
HIV testing will be done at all visits. TFV-DP DBS will be done at months 1, 3 and 6 to look at correlation of self-reported and actual measured PrEP compliance.
Drug Concentrations will be measured using the TFV-DP DBS at the Program for HIV Prevention and Treatment (PHPT), Chiang Mai. TFV-DP DBS levels ≥ 700 fmol/punch will be taken as adherence
- Being tested
- 'Project Raincoat' Mobile Phone Application
- Keywords
- PrEP adherence, Youth, Adolescents, MSM, HIV Prevention, Mobile Health
- Medical subject headings
- Medication Adherence, Adolescent Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
'Project Raincoat' Mobile Phone ApplicationBehavioural
Mobile phone application with weekly input channels for PrEP use, condom use, number of sex partners and sex acts and a calculation of self-HIV risk feedback scoring. Scoring system for attendance of visits, normal blood tests and use of application. Points redeemable for cash. Optional alarm system to remind to take medications and attend visits.
| Study group | Role | What they receive |
|---|---|---|
| Novel Intervention | Experimental | Use of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services Receives: Behavioral: 'Project Raincoat' Mobile Phone Application |
| Standard Intervention | No intervention | Use of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services |
What is being measured
The primary outcome is the main question the study is designed to answer.
PrEP Adherence
Self-Reported Adherence
Measured: Weekly self-reported adherence for a period of 6 months following randomization
PrEP Adherence at 3 months
Measured Serum TDF-DP Level (from dried blood spots)
Measured: Measured at month 3 (measure of 17 day half life of TDF-DP)
PrEP Adherence at 6 months
Measured Serum TDF-DP Level (from dried blood spots)
Measured: Measured at month 6 (measure of 17 day half life of TDF-DP)
Secondary outcomes (8)
HIV infection rates
seroconversion rates whilst on PrEP during study
Measured: duration of study (6 months)
Rates of Urethral Neisseria gonorrhea
Rates of Urethral Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) urine testing
Measured: duration of study (6 months)
Behaviour Risk-Taking
Composite calculated score of risk taking based on self-reported condom use, PrEP tablets taking, number of sexual partners in preceding one month. Scores will equate to risk levels of low, medium, high and very high.
Measured: duration of study (6 months)
Rates of Anal Neisseria gonorrhea
Rates of Anal Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) from anal swab samples
Measured: duration of study (6 months)
Rates of Urethral Chlamydia trachomatis
Rates of Urethral Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) urine testing
Measured: duration of study (6 months)
Rates of Anal Chlamydia trachomatis
Rates of Anal Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) from anal swab samples
Measured: duration of study (6 months)
Rates of Syphilis Infection
Rates of positive treponemal blood tests
Measured: duration of study (6 months)
Rates of Hepatitis B infection
Rates of positive HbsAg blood tests
Measured: At initial project visit (month 0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2018
- Study start1 Mar 2018
- Primary completion15 Dec 2019
- Study completion15 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Adherence, MedicationStudies of the same condition, open and under way.
- More trials run by Chulalongkorn UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- half of study participants will receive the intervention
- Masking
- None (open label)
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chulalongkorn University
- Sponsor type
- University, hospital or other
- Collaborators
- Thai Red Cross AIDS Research Centre, International AIDS Society
- Responsible party
- Principal investigator, Wipaporn Natalie Songtaweesin, MD., Chulalongkorn University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03778892
- Sponsor's protocol ID
- 2017/472-SON
- Acronym
- YouthPrEP
- Status last verified
- Jan 2020
- First submitted
- 8 Dec 2018
- Last updated
- 23 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, Cressey TR, Moonwong J, Vasinonta A, Saisaengjan C, Chinbunchorn T, Puthanakit T. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561. doi: 10.2196/25561.
PubMed 35451976Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, Chinbunchorn T, Janyam S, Linjongrat D, Puthanakit T; CE-PID - TRC Adolescent Study Team. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25564. doi: 10.1002/jia2.25564.
PubMed 32869511
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thailand
- ClinicalTrials.gov ID
- NCT03778892
- Acronym / sponsor ID
- YouthPrEP / 2017/472-SON
- Keywords
- PrEP adherence, Youth, Adolescents, MSM, HIV Prevention, Mobile Health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Chulalongkorn UniversityUniversity, hospital or other
- Collaborators
- Thai Red Cross AIDS Research Centre, International AIDS Society
- Study start
- 1 Mar 2018 (actual)
- Primary completion
- 15 Dec 2019 (actual)
- Study completion
- 15 Dec 2019 (actual)
- First posted
- 19 Dec 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.
Detailed description
OBJECTIVES
Primary Objectives:
To study PrEP adherence in adolescent MSM who are at high risk of HIV acquisition.
Secondary Objectives:
To study
- Rates of HIV infection
- Rates of sexually transmitted infections (STIs)
- Sexual risk taking behaviours In adolescent MSM who are at high risk of HIV infection.
HYPOTHESES:
- The investigators hypothesize that youth-focused interventions will produce superior adherence to PrEP from 50% with standard interventions to 70% with youth focused interventions.
- The investigators hypothesize that adherence to PrEP varies by the level of risk behavior one perceives. Participants who take higher risk behaviors will be more likely to adhere to PrEP than participants who have lower risk behaviors. STIs are expected to be more common among participants with higher levels of adherence if they are participants who have higher risk behaviors.
RESEARCH DESIGN:
Randomised control trial, behavioural intervention
RESEARCH METHODOLOGY
- Study population Volunteers aged 15 to under 20 years at high risk of HIV infection receiving PrEP under the 'Princess PrEP' project
- Inclusion Criteria
- Adolescent men who have sex with men
- At high risk of HIV infection (have at least one of the following)
- More than 1 sexual partner in the last 6 months
- Irregular condom use during sexual intercourse
- HIV positive sexual partner
- Age 15 to under 20 years old
- A desire to take PrEP to prevent HIV infection
- Tested HIV negative within 1 month of enrolment
- Able to provide written consent or assent to take part in the clinical trial
- Exclusion criteria Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy
- Study recruitment
- Eligible persons presenting to the Thai Red Cross Anonymous Clinic (TRCARC) or its affiliated community based organizations (Rainbow Sky Association Thailand (RSAT) Ramkamhaeng, Sex Workers in Action Group (SWING) Bangkok will be asked by counsellors on their interest to join the study.
- Number of participants to be studied: 200
- Informed consent process/ informed assent The research doctor will explain to potential participants about the purposes of the study and allow them to ask any questions they may have on it, and will be given time to make their decision. If a participant chooses to join the study, they will be asked for their written consent/assent and a copy of the informed consent/assent form given to them.
- Participants aged between 15 and 18 will be asked for assent. As this is a study on sexual health where disease prevention is of utmost concern, parental consent will not be asked for.
- Participants aged 18 to 19 will be asked for consent.
- Study procedure After informed consent or assent, all youth will commence once daily TFV/FTC 200/300mg. Volunteers will be randomized into arms 1 (standard intervention) or 2 (novel intervention strategy). Both groups will receive youth-focused counselling by trained counsellors and have access to an adolescent-friendly sexual health promotion website and social media page where they can get in contact with counsellors, doctors, fellow adolescents and function as a platform through which they can learn about good sexual health practices. Adolescents in arm 2 (novel intervention strategy) will also receive access to a mobile phone application.
Youth-focused counselling Counsellors will provide counselling that is friendly, non-judgmental and utilize motivational interviewing techniques where sessions are more collaborative rather than didactic.
Mobile Phone Application
- Password protection will ensure user privacy
- Will allow users to input weekly data on their:
- Sexual risk e.g. no sexual activity, sex with condoms, sex without condoms
- PrEP use e.g. whether or not participants take their PrEP
- The application will calculate a percentage of protection users have based on their data entry
- Points can be accumulated for application use, data input to the application, for attending appointments and also for normal STI and HIV screening results. Points can be redeemed for cash
- The overall goal of the application is to increase participant awareness of self-risk and motivation to protect themselves against HIV and STI infection
Participants will be followed up at months 1, 3 and 6. At each visit, participants will complete a questionnaire on drug adherence and sexual health risk behaviours.
STI testing will be done as an indirect marker of condom use at visits 1 and 6. This will involve blood testing for syphilis serology and nucleic acid amplification testing for gonorrhea, and chlamydia on swab samples.
HIV testing will be done at all visits. TFV-DP DBS will be done at months 1, 3 and 6 to look at correlation of self-reported and actual measured PrEP compliance.
Drug Concentrations will be measured using the TFV-DP DBS at the Program for HIV Prevention and Treatment (PHPT), Chiang Mai. TFV-DP DBS levels ≥ 700 fmol/punch will be taken as adherence
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- half of study participants will receive the intervention
| Arm | Type | Receives |
|---|---|---|
| Novel Intervention | Experimental | Behavioral: 'Project Raincoat' Mobile Phone ApplicationUse of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services |
| Standard Intervention | No intervention | –Use of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services |
Who may qualify
- Ages
- 15 to 19 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (9 listed)
- Adolescent men who have sex with men
- At high risk of HIV infection (have at least one of the following)
- Age 15 to under 20 years old
- A desire to take PrEP to prevent HIV infection
- Tested HIV negative within 1 month of enrolment
Key exclusion criteria (1 listed)
- Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 'Project Raincoat' Mobile Phone ApplicationMobile phone application with weekly input channels for PrEP use, condom use, number of sex partners and sex acts and a calculation of self-HIV risk feedback scoring. Scoring system for attendance of visits, normal blood tests and use of application. Points redeemable for cash. Optional alarm system to remind to take medications and attend visits. | Behavioural | Novel Intervention |
Primary outcome
PrEP Adherence
Time frame: Weekly self-reported adherence for a period of 6 months following randomization
Self-Reported Adherence
PrEP Adherence at 3 months
Time frame: Measured at month 3 (measure of 17 day half life of TDF-DP)
Measured Serum TDF-DP Level (from dried blood spots)
PrEP Adherence at 6 months
Time frame: Measured at month 6 (measure of 17 day half life of TDF-DP)
Measured Serum TDF-DP Level (from dried blood spots)
8 secondary outcomes
HIV infection rates
Time frame: duration of study (6 months)
Rates of Urethral Neisseria gonorrhea
Time frame: duration of study (6 months)
Behaviour Risk-Taking
Time frame: duration of study (6 months)
Rates of Anal Neisseria gonorrhea
Time frame: duration of study (6 months)
Rates of Urethral Chlamydia trachomatis
Time frame: duration of study (6 months)
Rates of Anal Chlamydia trachomatis
Time frame: duration of study (6 months)
Rates of Syphilis Infection
Time frame: duration of study (6 months)
Rates of Hepatitis B infection
Time frame: At initial project visit (month 0)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2020.
- Derived from this study: PubMed 35451976Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, Cressey TR, Moonwong J, Vasinonta A, Saisaengjan C, Chinbunchorn T, Puthanakit T. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561. doi: 10.2196/25561.
- Derived from this study: PubMed 32869511Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, Chinbunchorn T, Janyam S, Linjongrat D, Puthanakit T; CE-PID - TRC Adolescent Study Team. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25564. doi: 10.1002/jia2.25564.
- Individual participant dataSharing planned: No
Related trials for Adherence, Medication
Not yet recruiting
Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
Hypertension, Diabetes Mellitus, Type 2
Not yet recruiting
A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Medication Adherence, Glycemic Control for Diabetes Mellitus
Not yet recruiting
Assessing Psoriasis Treatment Outcomes
Psoriasis
Active, not recruiting
HERDA: Pharmacist-Led Culturally Adapted Intervention for Depression Medication Adherence
Depression
Not yet recruiting
Asthma Ctrl SMART Trial
Asthma in Children, Asthma Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 'Project Raincoat' Mobile Phone Application in people with Adherence, Medication and Adolescent Behavior, run by Chulalongkorn University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
PrEP Adherence (time frame: Weekly self-reported adherence for a period of 6 months following randomization). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03778892, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020.